Skip navigation
  • Sciety Labs 🧪 (Experimental)
  • Search
Sciety application utilities

Public and Global Health

  • Subscribe to feed (RSS)

Showing page 47 of 216 pages of list content

  • Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease

    This article's authors
    1. Devendra Bansal
    2. Jazeel Abdulmajeed
    3. Esraa Yassin
    4. Maha H M A Al-Shamali
    5. Soha S A Albayat
    6. Sayed M Himatt
    7. Farhan S Cyprian
    8. Tawanda Chivese
    9. Jesha M A Mundodan
    10. Hayat Khogali
    11. Rekayahouda Baaboura
    12. Anvar H Kaleeckal
    13. Mujeeb C Kandy
    14. Ali Nizar Latif
    15. Mohamed G Al-Kuwari
    16. Hamad Eid Al-Romaihi
    17. Abdullatif Al Khal
    18. Roberto Bertollini
    19. Mohamed H Al-Thani
    20. Elmobashar Farag
    21. Suhail A R Doi
    This article has 1 evaluations Latest evaluation on Apr 21, 2022 Published on Apr 18, 2022
  • When do persuasive messages on vaccine safety steer COVID-19 vaccine acceptance and recommendations? Behavioral insights from a randomised controlled experiment in Malaysia

    This article's authors
    1. Nicholas Yee Liang Hing
    2. Yuan Liang Woon
    3. Yew Kong Lee
    4. Joon Kim Hyung
    5. Nurhyikmah M. Lothfi
    6. Elizabeth Wong
    7. Komathi Perialathan
    8. Nor Haryati Ahmad Sanusi
    9. Affendi Isa
    10. Chin Tho Leong
    11. Joan Costa-Font
    This article has 1 evaluations Latest evaluation on Apr 21, 2022 Published on Apr 18, 2022
  • How did the COVID-19 Pandemic impact self-reported cancer screening rates in 12 Midwestern states?

    This article's authors
    1. Jason Semprini
    This article has 1 evaluations Latest evaluation on Apr 21, 2022 Published on Apr 18, 2022
  • COVID-19 and Curcumin: Using VOSviewer software to explore scientific landscapes – A bibliometric analysis

    This article's authors
    1. Mostafa H. Abd El Wahab
    This article has 2 evaluations Latest evaluation on May 9, 2022 Published on Apr 16, 2022
  • COVID-19 in the Mexican Social Security Institute (IMSS) population. Prevalent symptoms

    This article's authors
    1. Arturo Juárez-Flores
    2. Iván J. Ascencio-Montiel
    3. Juan Pablo Gutiérrez
    4. Stefano M. Bertozzi
    5. Víctor H. Borja-Aburto
    6. Gustavo Olaiz
    This article has 1 evaluations Latest evaluation on Apr 19, 2022 Published on Apr 16, 2022
  • To mask, or not to mask, Alice and Bob’s dating dilemma

    This article's authors
    1. Zhanshan (Sam) Ma
    2. Ya-Ping Zhang
    This article has 1 evaluations Latest evaluation on Apr 19, 2022 Published on Apr 16, 2022
  • Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers – Mexico, March–December 2021

    This article's authors
    1. Vesta L. Richardson
    2. Martín Alejandro Camacho Franco
    3. Aurora Bautista Márquez
    4. Libny Martínez Valdez
    5. Luis Enrique Castro Ceronio
    6. Vicente Cruz Cruz
    7. Radhika Gharpure
    8. Kathryn E. Lafond
    9. Tat S. Yau
    10. Eduardo Azziz-Baumgartner
    11. Mauricio Hernández Ávila
    This article has 1 evaluations Latest evaluation on Apr 19, 2022 Published on Apr 17, 2022
  • Predictors and barriers for the management of non-communicable diseases among older Syrian refugees amidst the COVID-19 pandemic in Lebanon: A cross-sectional analysis of a multi-wave survey

    This article's authors
    1. Stephen J. McCall
    2. Tanya El Khoury
    3. Noura Salibi
    4. Berthe Abi Zeid
    5. Maria El Haddad
    6. Marwan F. Alawieh
    7. Sawsan Abdulrahim
    8. Monique Chaaya
    9. Hala Ghattas
    10. Abla Sibai
    This article has 1 evaluations Latest evaluation on Apr 19, 2022 Published on Apr 17, 2022
  • Profile of Brazilian inpatients with COVID-19 vaccine breakthrough infection and risk factors for unfavorable outcome

    This article's authors
    1. Matheus A. S de Jesus
    2. Natália S. Hojo-Souza
    3. Thiago R. de Moraes
    4. Daniel L. Guidoni
    5. Fernanda S. H de Souza
    This article has 1 evaluations Latest evaluation on Apr 19, 2022 Published on Apr 16, 2022
  • Effectiveness of ChAdOx1 nCoV-19 Corona Virus Vaccine (Covishield™) in preventing SARS-CoV2 infection, Chennai, Tamil Nadu, India, 2021

    This article's authors
    1. Sharan Murali
    2. Manikandanesan Sakthivel
    3. Kamaraj P
    4. Vettrichelvan Venkataswamy
    5. Jeromie Wesley Vivian Thangaraj
    6. Anita Shete
    7. Alby John
    8. Jaganathan Arjun
    9. Girish Kumar C P
    10. Pragya D Yadav
    11. Rima Sahay
    12. Triparna Majumdar
    13. Manisha Dhudhmal
    14. Azhagendran Sivalingam
    15. Sudha Rani D
    16. Augustine D
    17. Vijayaprabha R
    18. Murali Mohan M
    19. Suresh A
    20. Punita M
    21. Elavarasu G
    22. Prabhakaran C
    23. Dhana Priya Vadhani S
    24. Prakash M
    25. Ezhil P
    26. Ganeshkumar Parasuraman
    27. Jagadeesan M
    28. Manish S Narnaware
    29. Gagandeep Singh Bedi
    30. Prabhdeep Kaur
    31. Manoj V Murhekar
    This article has 1 evaluations Latest evaluation on Apr 19, 2022 Published on Apr 16, 2022
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information